Foghorn Therapeutics Inc. FHTX
2.13 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:01 PM EST
2.13 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
2.08 Day range 2.20
1.79 52-week range 7.61
- YTD
- -60.56%
- 1 year
- -49.41%
Financial health
Altman Z-Score
-4.44 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -4.6×
FY 2018 5y median -3.0× FY 2025
P/S 11.0×
FY 2018 5y median 11.5× FY 2025
P/B -3.1×
FY 2018 5y median -3.1× FY 2025
P/FCF -3.9×
FY 2018 5y median -2.6× FY 2025
EV/EBITDA -4.2×
FY 2018 5y median -2.6× FY 2025
EV/Sales 9.7×
FY 2018 5y median 10.7× FY 2025
FCF Yield -25.3%
FY 2018 5y median -25.3% FY 2025
Profitability
Gross Margin 89.2%
FY 2018 5y median 100.0% FY 2025
Operating Margin -265.6%
FY 2018 5y median -454.3% FY 2025
Net Margin -240.3%
FY 2018 5y median -383.2% FY 2025
ROE 68.5%
FY 2018 5y median 68.5% FY 2025
ROIC -58.9%
FY 2018 5y median -45.4% FY 2025
ROA -37.5%
FY 2018 5y median -30.5% FY 2025
Growth (YoY)
Revenue 36.8%
FY 2018 FY 2025
Operating Income 20.0%
FY 2018 FY 2025
EPS (diluted) 25.3%
FY 2018 FY 2025
Free Cash Flow 15.0%
FY 2018 FY 2025
Financial Health
Current Ratio 2.7×
FY 2018 5y median 4.1× FY 2025
Quick Ratio 2.7×
FY 2018 5y median 4.1× FY 2025
Debt / Equity -0.4×
FY 2018 5y median -0.4× FY 2025
Net Debt / EBITDA 0.6×
FY 2018 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
